These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 11298482)
1. Atorvastatin: in the management of hyperlipidaemia. Ray SK; Rege NN J Postgrad Med; 2000; 46(3):242-3. PubMed ID: 11298482 [No Abstract] [Full Text] [Related]
2. Atorvastatin: a new agent for hyperlipidemia. Kupecz D Nurse Pract; 1997 Nov; 22(11):87-8, 90, 93. PubMed ID: 9403876 [No Abstract] [Full Text] [Related]
3. Liptruzet: a combination of ezetimibe and atorvastatin. Med Lett Drugs Ther; 2013 Jun; 55(1419):49-50. PubMed ID: 23797796 [No Abstract] [Full Text] [Related]
4. [Prevention of cardiovascular diseases: Value of CSE inhibitors in the management of lipid metabolism disorders]. Z Kardiol; 1998 Apr; 87(4 Suppl Stellenwer):1-4. PubMed ID: 9618894 [No Abstract] [Full Text] [Related]
5. [Fluvastatin in a comparative study. Are there substance-specific differences between various CSE-inhibitors?]. Internist (Berl); 1999 Mar; 40(3 Suppl Gibt Es):1-4. PubMed ID: 10192028 [No Abstract] [Full Text] [Related]
9. Effects of atorvastatin (10 mg) on hemostatic and inflammatory parameters in hyperlipidemic patients with angiographically proven coronary artery disease. Tekin A; Tekin G; Güzelsoy D; Kaya A; Gürel CV; Yiğit Z; Ulutin T Am J Cardiol; 2004 Jul; 94(2):206-9. PubMed ID: 15246903 [TBL] [Abstract][Full Text] [Related]
10. Journal Watch: evidence that Atorvastatin reduces the risk of stroke and myocardial infarction in patients with type 2 diabetes, but with no evidence of dyslipidaemia. Gangaidzo IT Cent Afr J Med; 2005; 51(11-12):125-6. PubMed ID: 17447346 [No Abstract] [Full Text] [Related]
11. Atorvastatin--a new lipid-lowering drug. Med Lett Drugs Ther; 1997 Mar; 39(997):29-31. PubMed ID: 9121394 [No Abstract] [Full Text] [Related]